KDR and neoplasm: While these effects are linked to modulation of the tumor microenvironment due to an inhibitory effect on vascular endothelial growth factor receptor (VEGFR), the immunomodulatory effect of TKIs on tumor cell phenotypes has not been investigated in HCC.